Alnylam Pharmaceuticals
0 sources
Financials
0001628280-26-007497Alnylam Pharmaceuticals
Summary
Alnylam Pharmaceuticals is a business[1]. It ranks in the top 3% of business entities by monthly Wikipedia readership (463 views/month).[2]
Key Facts
- Alnylam Pharmaceuticals is in the country of United States[3].
- Alnylam Pharmaceuticals is in the country of US[4].
- Alnylam Pharmaceuticals's instance of is recorded as business[5].
- Alnylam Pharmaceuticals's instance of is recorded as public company[6].
- Alnylam Pharmaceuticals's instance of is recorded as biopharmaceutical company[7].
- Alnylam Pharmaceuticals's headquarters location is recorded as Cambridge[8].
- Alnylam Pharmaceuticals's stock exchange is recorded as Nasdaq[9].
- Alnylam Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
- 2002 marks the founding of Alnylam Pharmaceuticals[11].
- 2003-05-08 marks the founding of Alnylam Pharmaceuticals[12].
- Alnylam Pharmaceuticals's official website is recorded as http://www.alnylam.com/[13].
- Alnylam Pharmaceuticals's legal form is recorded as Delaware corporation[14].
- Alnylam Pharmaceuticals's legal form is recorded as XTIQ[15].
- Alnylam Pharmaceuticals's number of viewers/listeners is recorded as {'amount': '+482666'}[16].
- Alnylam Pharmaceuticals's social media followers is recorded as {'amount': '+13619'}[17].
- Alnylam Pharmaceuticals's social media followers is recorded as {'amount': '+12743'}[18].
- Alnylam Pharmaceuticals's social media followers is recorded as {'amount': '+14908'}[19].
- Alnylam Pharmaceuticals's social media followers is recorded as {'amount': '+16036'}[20].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900S3ZI14OWRJII50[21]
-
Registered legal name: Alnylam Pharmaceuticals, Inc.[22]
-
Legal jurisdiction: US-DE[23]
-
GLEIF entity category: GENERAL[24]
-
Legal form (ISO 20275 ELF): XTIQ[25]
-
Entity status: ACTIVE[26]
-
LEI registration status: ISSUED[27]
-
Entity created: 2003-05-08[28]
-
LEI first registered: 2018-10-19[29]
-
LEI last updated: 2025-06-24[30]
-
LEI next renewal: 2026-08-10[31]
-
Managing LOU: 5299000J2N45DDNE4Y28[32]
-
Registration authority: RA000602[33]
-
Authority entity ID: 3651907[34]
-
Conformity flag: CONFORMING[35]
Body
Founding
Recorded inception include 2002[11] and 2003-05-08[12].
Operations
Alnylam Pharmaceuticals's headquarters location is recorded as Cambridge[8].
Industry
Alnylam Pharmaceuticals's industry is recorded as pharmaceutical industry[10].
Ownership
Alnylam Pharmaceuticals's stock exchange is recorded as Nasdaq[9].
Why It Matters
Alnylam Pharmaceuticals ranks in the top 3% of business entities by monthly Wikipedia readership (463 views/month).[2] It has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[36]